| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IL-5 R alpha | Human IL-5 R alpha / CD125 Protein, Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $410.00 100ug | ||
| IL-5 R alpha | Human IL-5 R alpha / CD125 Protein, His Tag, low endotoxin (MALS & BLI verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $325.00 50ug | ||
| IL-5 R alpha | Avitag ILA-H82F5 | Biotinylated Human IL-5 R alpha / CD125 Protein, Avitag™,Fc Tag (MALS verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $360.00 25ug | |
| IL-5 R alpha | Mouse IL-5 R alpha / CD125 Protein, His Tag (MALS & SPR verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $350.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| IL-5 CAR-T Cell Therapy (Zhejiang University) | Phase 1 Clinical | Zhejiang University | Hematologic Diseases; Neoplasms | Details | |
| Trabikibart | CSL-311 | Phase 1 Clinical | Csl Ltd | Asthma | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Benralizumab | KHK-4563; MEDI-563; BIW-8405; BIW-8405-IL-5R | Approved | Biowa Inc, Medimmune Llc | Fasenra, 凡舒卓 | United States | Asthma | Astrazeneca Ab | 2017-11-14 | Asthma; Asthma, Exercise-Induced; Bronchiectasis; Chronic Urticaria; Dermatitis; Dermatitis, Atopic; Drug Hypersensitivity Syndrome; Eczema; Eosinophilia; Eosinophilic Asthma; Eosinophilic Esophagitis; Eosinophilic gastroenteritis (EG); Eosinophilic Granulomatosis With Polyangiitis; Gastroenteritis; Genetic Diseases, Inborn; Granulomatosis with Polyangiitis; Hematologic Diseases; Hypereosinophilic Syndrome; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases; Leukocyte Disorders; Nasal Polyps; Pemphigoid, Bullous; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Sinusitis; Skin Diseases; Skin Diseases, Eczematous; Skin Diseases, Genetic | Details |